Abstract
Maggini and colleagues examine the evidence on cholinesterase inhibitors for treating dementia. "What seemed a biologically plausible intervention," they say, "has not led to a proven, real improvement in patients' well-being."
MeSH terms
-
Alzheimer Disease / drug therapy*
-
Cholinesterase Inhibitors / therapeutic use*
-
Cognition Disorders / classification
-
Cognition Disorders / drug therapy*
-
Dementia, Vascular / drug therapy*
-
Drug Industry
-
Evidence-Based Medicine
-
Humans
-
Lewy Body Disease / drug therapy*
-
Parkinson Disease / complications
-
Randomized Controlled Trials as Topic
-
Reproducibility of Results
-
Risk Factors
-
Treatment Outcome
Substances
-
Cholinesterase Inhibitors